Translations:Dyslipidemia/2/en: Difference between revisions

From Azupedia
Jump to navigation Jump to search
FuzzyBot (talk | contribs)
Importing a new version from external source
 
(No difference)

Latest revision as of 17:52, 13 April 2024

Information about message (contribute)
This message has no documentation. If you know where or how this message is used, you can help other translators by adding documentation to this message.
Message definition (Dyslipidemia)
'''Dyslipidemia''' is a metabolic disorder characterized by abnormally high or low amounts of any or all [[lipid]]s (e.g. [[fat]]s, [[triglyceride]]s, [[cholesterol]], [[phospholipid]]s) or [[lipoprotein]]s in the [[blood]]. Dyslipidemia is a risk factor for the development of [[atherosclerotic cardiovascular disease]]s (ASCVD), which include [[coronary artery disease]], [[cerebrovascular disease]], and [[peripheral artery disease]]. Although dyslipidemia is a risk factor for ASCVD, abnormal levels don't mean that lipid lowering agents need to be started. Other factors, such as comorbid conditions and lifestyle in addition to dyslipidemia, is considered in a cardiovascular risk assessment. In developed countries, most dyslipidemias are [[hyperlipidemia]]s; that is, an elevation of lipids in the blood. This is often due to [[diet (nutrition)|diet]] and lifestyle. Prolonged elevation of [[insulin]] resistance can also lead to dyslipidemia. Likewise, increased levels of [[OGT (gene)|O-GlcNAc transferase (OGT)]] may cause dyslipidemia.

Dyslipidemia is a metabolic disorder characterized by abnormally high or low amounts of any or all lipids (e.g. fats, triglycerides, cholesterol, phospholipids) or lipoproteins in the blood. Dyslipidemia is a risk factor for the development of atherosclerotic cardiovascular diseases (ASCVD), which include coronary artery disease, cerebrovascular disease, and peripheral artery disease. Although dyslipidemia is a risk factor for ASCVD, abnormal levels don't mean that lipid lowering agents need to be started. Other factors, such as comorbid conditions and lifestyle in addition to dyslipidemia, is considered in a cardiovascular risk assessment. In developed countries, most dyslipidemias are hyperlipidemias; that is, an elevation of lipids in the blood. This is often due to diet and lifestyle. Prolonged elevation of insulin resistance can also lead to dyslipidemia. Likewise, increased levels of O-GlcNAc transferase (OGT) may cause dyslipidemia.